Lineage Cell (Israel) Probability of Future Stock Price Finishing Under 1.96
| LCTX Stock | ILA 179.00 8.10 4.33% |
Lineage |
Lineage Cell Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Lineage Cell for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Lineage Cell Therape can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Lineage Cell Therape had very high historical volatility over the last 90 days | |
| The company reported the revenue of 1.83 M. Net Loss for the year was (11.93 M) with profit before overhead, payroll, taxes, and interest of 1.44 M. | |
| Lineage Cell Therapeutics, has accumulated about 68.75 M in cash with (23.33 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.41. |
Lineage Cell Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Lineage Stock often depends not only on the future outlook of the current and potential Lineage Cell's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Lineage Cell's indicators that are reflective of the short sentiment are summarized in the table below.
| Float Shares | 126.29M | |
| Average Daily Volume Last 10 Day | 167.87k | |
| Average Daily Volume In Three Month | 167.87k |
Lineage Cell Technical Analysis
Lineage Cell's future price can be derived by breaking down and analyzing its technical indicators over time. Lineage Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Lineage Cell Therapeutics,. In general, you should focus on analyzing Lineage Stock price patterns and their correlations with different microeconomic environments and drivers.
Lineage Cell Predictive Forecast Models
Lineage Cell's time-series forecasting models is one of many Lineage Cell's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Lineage Cell's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Lineage Cell Therape
Checking the ongoing alerts about Lineage Cell for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Lineage Cell Therape help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Lineage Cell Therape had very high historical volatility over the last 90 days | |
| The company reported the revenue of 1.83 M. Net Loss for the year was (11.93 M) with profit before overhead, payroll, taxes, and interest of 1.44 M. | |
| Lineage Cell Therapeutics, has accumulated about 68.75 M in cash with (23.33 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.41. |
Other Information on Investing in Lineage Stock
Lineage Cell financial ratios help investors to determine whether Lineage Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Lineage with respect to the benefits of owning Lineage Cell security.